Why is Godavari Drugs falling/rising?

As of 15-Jul, Godavari Drugs Ltd is currently priced at 89.00, reflecting an increase of 0.7, or 0.79%. The stock has shown a slight upward movement, gaining 0.91% over the last two days, although it has underperformed its sector by 0.46% today. Despite this recent gain, the stock is trading below its moving averages across various timeframes, indicating a potential weakness in its price momentum. Over the past year, Godavari Drugs has generated a return of -15.40%, with profits declining by 22.1%. The company's valuation appears attractive with a ROCE of 12.3 and a lower enterprise value compared to peers, but it faces challenges such as a high Debt to EBITDA ratio and weak long-term fundamentals. In the broader market context, Godavari Drugs has underperformed the Sensex, which has gained 5.67% year-to-date, while the stock has declined by 18.61%. The stock's recent performance contrasts with the benchmark's slight decline of 1.36% over the past week, indicating that while the stock is experiencing a minor recovery, it still lags behind the overall market. The liquidity of the stock remains adequate, with an increase in delivery volume, suggesting some investor interest, but the overall sentiment appears cautious given the company's recent financial struggles and negative growth trends.